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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYTools for rapid and efficient transgenesis in ‘‘safe harbor’’ loci in an isogenic context remain important to exploit the possibilities of hu-
man pluripotent stem cells (hPSCs).We created hPSCmaster cell lines suitable for FLPe recombinase-mediated cassette exchange (RMCE)
in theAAVS1 locus that allow generation of transgenic lineswithin 15 dayswith 100%efficiency andwithout random integrations. Using
RMCE, we successfully incorporated several transgenes useful for lineage identification, cell toxicity studies, and gene overexpression to
study the hepatocyte lineage. However, we observed unexpected and variable transgene expression inhibition in vitro, due to DNA
methylation and other unknown mechanisms, both in undifferentiated hESC and differentiating hepatocytes. Therefore, the AAVS1
locus cannot be considered a universally safe harbor locus for reliable transgene expression in vitro, and using it for transgenesis in
hPSC will require careful assessment of the function of individual transgenes.INTRODUCTION
As it has been the case for studies aiming to understand
mouse development, transgenesis is an indispensable tool
to fully exploit the potential of human pluripotent stem
cells (hPSCs). Recent technological advances using site-spe-
cific nucleases (Zinc Finger Nucleases [ZFNs], Transcription
Activator-Like Effector Nucleases [TALENs], or clustered
regularly interspaced short palindromic repeats [CRISPR]/
Cas9 system) have allowed to overcome major hurdles
hampering genome editing in hPSCs (Li et al., 2014).
Gene targeting constitutes the method of choice for trans-
genesis in hPSCs as it eliminates the drawbacks of random
integration methods linked to possible insertional muta-
genesis and epigenetic silencing, which lead to variegated
transgene expression in subpopulations of cells (Cherry
et al., 2000; Yao et al., 2004).918 Stem Cell Reports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 TheDespite these advances, gene targeting in hPSCs still re-
mains a laborious process, and the development of tools
that allow rapid and versatile genetic modification remains
of great interest. Site-specific recombinase-mediated ho-
mologous recombination with pre-integrated recombina-
tion target sequences in ‘‘safe harbor’’ loci, like the Rosa26
orHprt1 loci, has been extensively used inmouse transgen-
esis. Such safe harbor loci are found in ubiquitously ex-
pressed genes with transcriptional competent conforma-
tion that allows stable transgene expression with no
detrimental effect on the biology of the modified cells. In
hPSCs, Cre recombinase systems for recombinase-medi-
ated cassette exchange (RMCE) have been developed either
in the adeno-associated virus integration site 1 (AAVS1
locus) (Ramachandra et al., 2011; Tay et al., 2013; Zhu
et al., 2013) or by random integration (Du et al., 2009),
though such methods do not constitute a technicalAuthors
improvement over gene targeting approaches using
nucleases.
The AAVS1 locus, located in the first intron of the
PPP1R12C gene on chromosome 19 has been described to
meet the ‘‘safeharbor’’ requirements inavarietyof cell types
including hPSCs. Though the function of the PPP1R12C
gene has not been fully investigated, hPSCs retain pluripo-
tency after targeting. In addition, transgene expression in
the AAVS1 locus appears stable in undifferentiated hPSCs
and following differentiation to all three germ layers
in vitro and in vivo (DeKelver et al., 2010; Hockemeyer
et al., 2009; Lombardo et al., 2011; Qian et al., 2014; Smith
et al., 2008).
Thegoalof this studywas togenerateanefficient andrapid
method of transgenesis in the AAVS1 locus of hPSCs, based
on RMCE using positive and negative selection to allow
the generation of non-clonal transgenic lines, to enable sta-
ble incorporation of lineage-specific promoters, molecular
response sensors, or inducible gene overexpression. We
focused on validating the applicability of the RMCE in the
AAVS1 locus during hepatocyte differentiation as only few
studies have used transgenesis to characterize this lineage
in human (Davis et al., 2008; Duan et al., 2007; Ishii et al.,
2008; Umeda et al., 2013; Wang et al., 2011). Using ZFNs
to pre-integrate FRT sequences in the AAVS1, we generated
an RMCE system that allows the generation of cell lines
with 100% efficiency and without random integrations in
±15 days.We demonstrate the suitability of the locus to sup-
port several applications for the studyof thehepatocyte line-
age, although we found variable transgene inhibition in the
pluripotent and differentiated state of hESC in vitro in a po-
tential lineage-dependent manner, which appears to not be
present in teratomas in vivo. Our results suggest that the
AAVS1 locus is not as safe as generally believed.RESULTS
Generation of an RMCE-Suitable Master Cell Line
and RMCE
The master cell line (MCL) was generated as explained in
the Supplemental Experimental Procedures (Figure 1A).
Amplification of the wild-type allele and Southern blot-
ting was performed to determine whether the integration
was mono or biallelic and to rule out random integration
events (Figures 1B and 1C). Two heterozygously targeted
clones were chosen for further characterization of mainte-
nance of pluripotency (teratoma formation assay was car-
ried out using a protocol approved by the Institutional
Ethics Committee at KU Leuven) and a normal karyotype
(Figures 1D, 1E, and S1A). In agreement with previous
studies, GFP was homogeneously expressed in undifferen-
tiated and differentiated cells from the selected clones,Stem Cell Rwhich was stable during passaging and differentiation
(Figures 1F and 1G).
RMCEwas thenperformedbynucleofectionof themaster
cell line with the donor vector pZ:F3-P CAGGS tdTPH-F and
the FLPe-expressing vector (Figure 2A). Control conditions
without donor or without FLPe were included to evaluate
the rate of random integration events and the specificity
of the RMCE mediated by FLPe. The cells were selected
withprogressively increasing concentrations of puromycin,
to select for cells integrating the donor plasmid, combined
with negative selection with FIAU, to select for exchange
events resulting in loss of the HSV-tk suicide gene and to
eliminate possible random integrations (Figure 2B). We de-
tected an average of 12.8 ± 6.8 (n = 6) PuroR/FIAUR-resistant
RMCEcolonies, all homogeneous tdT+/GFP– demonstrating
that efficiency of recombination by cassette exchange was
100% (Figure 2B). No resistant colonies were obtained
when cells were transfected with the donor alone, indi-
cating that recombination was mediated by FLPe between
theFRTsequences and that thenegative selectionefficiently
selects against random integration events. Following selec-
tion, the non-clonal newly generated RMCE lines (all
PuroR/FIAURcells)were subjected toPCRandSouthernblot-
ting (Figures 2C and 2D) to confirm full RMCE and absence
of random integration of either the donor or FLPe plasmids.
RMCE lines maintained pluripotency (Figure 2E).
A similar master cell line was generated in an iPSC line,
and FLPe-mediated RMCEwas validated (Figure 1C; Figures
S1A–S1E). Therefore, this constitutes a method allowing
highly efficient complete RMCE in ±15 days, without
random integrations and without the need for single col-
ony characterization after recombination.
Lineage Tracing Using the OCT4 Promoter Reveals
Inhibition Exerted by the AAVS1 Locus
To demonstrate the suitability of the AAVS1 locus for line-
age identification and tracing studies, we recombined the
OCT4 promoter-GFP RMCE vector pZ:F3-P OCT4p-GFP-F
in this locus (Figure 3A, top; Figure S2). Contrary to
what was observed when the OCT4p was randomly inte-
grated in hESC (Gerrard et al., 2005), we did not detect
OCT4p promoter activity (Figure 3B). Thus, the AAVS1 lo-
cus might inhibit or silence the OCT4p despite the insu-
lator activity ascribed to a DNase hypersensitive region
(DHR) region present in the AAVS1 (Ogata et al., 2003).
The epigenetic status of the AAVS1 was previously
described as open chromatin by DNase hypersensitivity
and chromatin immunoprecipitation (ChIP) assays, but
no study has assessed the DNA methylation in this region.
We performed bisulfite sequencing of different fragments
of the AAVS1 locus in wild-type, undifferentiated hESCs
and observed DNA hypo-methylation upstream of the
DHR (33% methylated CpGs), total absence ofeports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 The Authors 919
Figure 1. Generation and Characterization of FRT-Containing Master Cell Lines in hESC
(A) The AAVS1 gene targeting vector pZ:F3-CAGGS GPHTK-F, containing homology regions to the PPP1R12C locus (thick bars) and flanking
FRTs (additional details in the Supplemental Information). The 50 internal Southern blot probe (red bar) and fragment sizes of DNA di-
gested with EcoRI (E) are indicated.
(B) PCR genotyping of the master cell line (MCL) clones using primer sets depicted in (A) for 50/30 random integration (RI), amplification of
the wild-type allele (WT), and 50/30 junction assays (JA). NTC, negative template control.
(C) Southern blot of the wild-type cells and clones of iPSC (iMCL) and ESC (MCL) master cell lines.
(D) Top: Expression of pluripotency markers of a representative MCL clone by immunocytochemistry (scale bars, 100 mm). Bottom: TRA-1-
60 expression in two clones determined by FACS.
(E) Karyogram of two hESC MCL clones.
(F) GFP expression in undifferentiated hESC MCL after more than 20 passages.
(G) Immunohistochemistry of GFP expression in teratoma of one MCL clone and WT cells (scale bars, 50 mm).methylation in the AAVS1 integration site region (1.3%
methylated CpGs), but hyper-methylation in the ZFN tar-
geting region (93.5% methylated CpGs) (Figure 3C, top
and middle). The integrated OCT4p-GFP DNA sequence
was also found nearly 100% methylated, consistent with
the notion that de novo DNA methylation could spread
from the proximal ZFN target site into the transgene (Fig-
ure 3C, bottom). Because insulators are known to have a
barrier function and block spreading of adherent methyl-
ated domains (Dickson et al., 2010), we flanked the trans-920 Stem Cell Reports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 Thegene with two inverted tandem repeat copies of the cHS4
insulator (Figure 3A, bottom; Figure S2). As expected, in-
sulators prevented DNA methylation of the transgene
(Figure 3C, bottom), and the promoter activity was
restored yielding nearly 100% GFP+ cells in undifferenti-
ated cells and loss of GFP during differentiation (Figures
3B, 3D, and 3E). Thus, the AAVS1 locus exerts inhibition
in undifferentiated hESC by promoting de novo DNA
methylation of the transgene, which can be overcome
with insulators.Authors
Figure 2. FLPe-Mediated RMCE Allows Generation of Fully Recombined Lines, Free of Random Integration, with 100% Efficiency
(A) The RMCE donor vector pZ:F3-P CAGGS tdTPH-F (top) flanked by heterotypic FRT sequences (additional details in the Supplemental
Information), original master cell line (MCL) and resulting RMCE line (RMCEL) are depicted. Red, blue, and green lines represent the 50
internal, puromycin, and 30 external Southern blot probes, respectively. Fragment sizes of DNA digested with NcoI (N) are indicated.
(B) Timeline of RMCEL generation (all PuroR/FIAUR cells) and selection program with FACS histograms representing the cassette exchange.
(C) PCR characterization of independent RMCELs using primer sets depicted in (A) for 50/30 JA of the MCL or RMCEL, 50/30 RI of the donor or
FLPe-expressing vector. Wild-type (WT), MCL#13, and controls for random and FLPe integration (+RI and +FLPe) and no template control
(NTC) samples were included.
(D) Southern blotting of hESC wild-type (WT) cells, MCLs and RMCELs.
(E) Teratoma formation assay of two RMCE lines.
Scale bars, 50 mm (black) and 100 mm (white).Lineage Identification during Hepatocyte
Specification
Wenext tested whether lineage identification during hepa-
tocyte differentiation could be achieved by incorporating
cell type specific promoters for a mesoendoderm marker
gene, GOOSECOID (GSCp), a hepatocyte endoderm gene,
ALFAFETOPROTEIN (AFP) enhancer-promoter (AFPe-p)
shown to be active in differentiating hESC (by stable
random integration of the transgene) (Ishii et al., 2008)
and the more mature hepatocyte marker gene ALPHA-1
ANTITRYPSIN (AAT) with APOLIPOPROTEIN E enhancer
and AAT promoter (APOeAATp) or minimal AAT promoterStem Cell R(AATp) shown to be active in human hepatocyte cell lines
(by transient transfection) and differentiating hESC (by
transduction of the differentiated progeny), respectively
(Duan et al., 2007; Lam et al., 2007), all flanked by two
inverted tandem repeat copies of the cHS4 insulator (Fig-
ure 4A). All these genes were expressed during differentia-
tion at the expected time points (Figure 4B). Stable cell lines
for each promoter were generated by RMCE and were
subsequently subjected to directed differentiation to the
hepatocyte lineage along with the wild-type hESC and
the master cell line as negative and positive controls
to gate GFP expression, respectively. Following directedeports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 The Authors 921
Figure 3. The AAVS1 Locus Mediates Transgene Silencing by DNA Methylation in Undifferentiated hESC
(A) The RMCE donor vectors pZ:F3-P OCT4p-GFP-F (top) and pZ:F3-P (cHS4)X4 OCT4p-GFP-F (bottom) contain the OCT4p-GFP-polyA cassette
without or with insulators (blue arrows), respectively.
(B) Representative data of GFP expression levels (microscopy and FACS) in undifferentiated wild-type (WT), master cell line (MCL) and
OCT4p without (OCT4p GFP) or with insulators (In OCT4p GFP). Scale bar, 100 mm.
(C) Middle: representation of the AAVS1 locus adapted from Ogata et al. (2003). Thin line: 4-kb-long sequence containing the AAVS1 locus.
Empty boxes: DNase hypersensitive region (DHR), Rep-binding site (RBS), and integration site (IS). Exon 1 (black box), homology regions
used for homologous recombination (striped boxes), and ZFN targeting site (gray line) are depicted. Bisulfite sequenced regions analyzed
in wild-type (WT) undifferentiated hESC: blue, gray, and red thick lines. The OCT4p-GFP RMCE lines (+/ insulators) and the fragment
analyzed by bisulfite sequencing (purple line) are below the ZFN site. Top and bottom show representative panels and percentages of the
results of bisulfite sequencing of the regions highlighted in the middle figure (n = 2 IEs).
(D) Top, scheme of the hepatic differentiation protocol: Activin (A), W (Wnt3a), B4 (BMP4), aF (aFGF), H (HGF), UD (undifferentiated), DE
(definitive endoderm), HE (hepatic endoderm), HB (hepatoblasts), and HP (hepatocytes). Bottom, OCT4 expression levels as percentage of
GFP+ cells and mRNA expression levels (relative expression [RE], mean ± SEM of n = 3 IEs).
(E) Immunocytochemistry of day 8 differentiated progeny. Scale bar, 100 mm.differentiation, the master cell line showed continued ho-
mogeneous GFP expression (Figure 4B). Approximately
15% of differentiating GSCp cells were GFP+ on day 4,
which decreased to ±5% on day 8, and no GFP+ cells were
detected by day 12, a pattern that reflected transcript levels
(Figure 4C). For the APOeAATp reporter line, we detected
2%–4% GFP+ cells on days 8, 12, and 16 of differentiation
(Figure 4B), which underestimated the number of AAT-ex-
pressing cells, more significantly in the final maturation
stage (day 16) where AAT gene expression increases as922 Stem Cell Reports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 Thecompared to day 12 (Figures 4D and 4F). No GFP+ cells
were found for AFPe-p and AATp reporter lines, even
though when integrated randomly, these promoters were
successfully used to isolate AFP and AAT expressing cells
from differentiating hESC (Duan et al., 2007; Ishii et al.,
2008).
On day 4, GFP+ cells were isolated from the differ-
entiating progeny of the GSCp line for further char-
acterization (Figure 4C). Compared with the unsorted
population, GSC transcripts were 2-fold higher in theAuthors
Figure 4. Activity of Lineage-Specific Promoters during Hepatocyte Commitment
(A) The RMCE donor vector pZ:F3-P (cHS4)X4 X-GFP-F contains lineage-specific promoters (Xp) flanked by insulators (blue arrows)
driving GFP.
(B) Timeline of cell morphology (SSC-FSC, top row) and GFP fluorescence (bottom rows) of wild-type (WT), master cell line (MCL), and
RMCELs with the indicated promoters during the hepatocyte differentiation. Left graphs: endogenous mRNA expression levels of GSC, AFP,
and AAT (relative expression, RE).
(C and D) Top, average percentage of GFP+ cells during differentiation and endogenous mRNA expression levels in GSCp (C) and APOeAATp
(D) RMCE lines. Bottom, mRNA expression profile of GFP+ and GFP– sorted cells (relative gene expression to unsorted cells) from GSCp (day
4, C) and APOeAATp (day 12, D) RMCELs. Data as mean ± SEM of n = 3 IEs.
(E and F) Immunocytochemistry of GSCp (day 4, E) and APOeAATp (day 12, F) RMCEL progenies. Areas with concentrated amount of positive
cells are shown.
Scale bar, 35 mm. *p < 0.05, **p < 0.001, and ***p < 0.0001 by Student’s t test.GSC-GFP+ cells and 4-fold lower in the GSC-GFP– cells.
GSC-GFP+ cells expressed higher levels of the mesoendo-
dermal markers T and MIXL1 and significantly lower
levels of OCT4. Interestingly, transcripts for the definitive
endoderm marker genes, GATA4, GATA6, CXCR4, SOX17,
and FOXA2, were 3- to 10-fold higher in the GSC-GFP+
cells compared with unsorted cells. The enrichment ofStem Cell Rchiefly definitive endoderm markers suggests that selec-
tion based on GFP transcribed by the GSCp on day 4
of differentiation enriches for cells that are being
committed to the endodermal lineage. This was further
substantiated by immunocytochemistry, demonstrating
co-expression of GFP with FOXA2 and SOX17
(Figure 4E).eports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 The Authors 923
We also isolated AAT-GFP+ and AAT-GFP– cells from d12
progeny of the APOeAATp line (Figure 4D). Compared
with unsorted cells, transcript levels for AAT were 6-fold
higher in the GFP+ cells and 9-fold lower in the GFP– frac-
tion, although AAT transcripts were still abundant in the
GFP– cells. Expression of HNF4a, ALB, and AFP was signifi-
cantly higher in theAPOeAATp-GFP+ cells and significantly
lower in the GFP– fraction. Immunocytochemistry
confirmed that GFP+ cells where AAT+ but also that many
AAT+ cells were not identified by the reporter (Figure 4F).
As AAT decreased in the negative fraction, the APOeAATp
correctly identified a subpopulationofAAT+ cellswithhigh-
est AAT transcript levels both on day 12 and 16 (Figure S3).
Thus, the GSCp and APOeAATp reporters identify specif-
ically GSC- and AAT-expressing cells, respectively, allowing
the identification, isolation, and characterization of these
two specific cell populations. However, despite presence of
the cHS4 insulators, the APOeAATp reporter only identified
a limited fraction of AAT+ cells on day 16, and the AFPp
and AATp did not activate in response to differentiation. To
investigate whether these limitations were hepatocyte spe-
cific, a non-hepatic promoter was tested. The HB9 motor
neuron-specific promoter, previously used to identify this
lineageby transductionofhESC-derivedprogeny (Marchetto
et al., 2008), yielded similar results as the APOeAATp (Fig-
ure S3B) indicatingthatproper lineage-specific reporteractiv-
ity intheAAVS1 ismost likelypromoter sequencedependent.
Use of the AAVS1 Locus as an Isogenic Locus for
Molecular Sensors
Molecular sensors with reporter cassettes are increasingly
used to assess cell function, health, or viability in response
to drugs or other stimuli (Lake et al., 2012). As an example
of a toxicology cassette suitable for mode of action studies
associatedwith drug toxicity, we recombined a necrosis fac-
tor kB (NF-kB) stress sensor into the AAVS1 locus by RMCE
(Figure 5A). Following treatment of the cells with tumor ne-
crosis factor alpha (TNF-a) for 48 hr, the fraction of tdT+
cells increased in a dose-dependent manner. A plateau of
±25% tdT+ cells was reached with concentrations of
50 ng/ml and higher (Figure 5B). The relatively lownumber
of cells positive for tdT is likely due to the fact that TNF-a
poorly activates NF-kB in hESC, as shown by the low induc-
tion of transcript levels of direct NF-kB target genesCXCL3,
NAF1, and NFKIa on day 0 (Figure 5C, left). To assess
whether the limited response reflects incomplete NF-kB re-
porter activation, we exposed ESC for 24 hr with 100 ng/ml
TNF-a, isolated tdT+ and tdT– cells by fluorescence-acti-
vated cell sorting (FACS), replated them, and after 3 days
re-challenged with TNF-a. TNF-a induced tdT response to
the same extent in the tdT+ and tdT– sorted cells (Figure 5D),
demonstrating that TNF-a activates NF-kBheterogeneously
in hESC due to poor induction capacity.924 Stem Cell Reports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 TheWe next tested the function of the NF-kB sensor in ESC
differentiated toward the hepatocyte lineage. When day
16 hepatocyte progeny was exposed to 100 ng/ml TNF-a
for 24 hr, again almost 30% tdT+ cells could be detected,
while non-induced cells showed a basal reporter activity,
probably indicatingminimal levels of culture-induced stress
(Figure 5E). As observed inundifferentiated cells, additionof
TNF-a onlymildly induced NF-kB direct target genes on day
16 (Figure 5C, right). Nevertheless, this indicated that the
NF-kB sensor is active in both undifferentiated and differen-
tiated cells and correctly reports for NF-kB activation.
We also assessed whether the NF-kB stress sensor activity
would be increased when the construct was flanked by in-
sulators. However, the percentage of tdT+ cells found
following treatment of undifferentiated or day 16 hepato-
cyte progeny with 100 ng/ml TNF-a was similar to the
original construct, while tdT protein expression (as mean
fluorescence intensity, MFI) was significantly and robustly
improved (Figure 5F). Therefore, in agreement with results
seen forOCT4p, the use of insulators improved the reporter
activity in the NF-kB sensitive cells.
Inducible Expression from AAVS1 Locus during
Hepatocyte Commitment
To assess whether it would be possible to generate an effi-
cient inducible expression system in the AAVS1 locus, we
generated an ‘‘all-in-one’’ donor vector for inducible
expression (Figure 6A). After recombination in the AAVS1
locus, the undifferentiated cells were treated with doxycy-
cline (DOXY) for 48 hr at different doses. No leaky tdT
expression was seen in the absence of DOXY, and the per-
centage of tdT+ cells increased in a dose-dependentmanner
reaching a plateau of ±75% activation when cells were
treated with 3 mg/ml DOXY for 2 days (Figure 6B).
We next determined whether tdT expression could also
be induced during differentiation of hPSCs toward the he-
patocyte lineage, by adding 3 mg/ml DOXY 2 days prior to
the start of differentiation (day 2, undifferentiated cells), or
starting on days 4, 8, or 12 during the hepatocyte differen-
tiation process. hPSC progeny expressed stable m2rtTA
levels throughout differentiation (Figure 6C). Addition of
DOXY (or higher concentrations up to 10 mg/ml) did not
affect the differentiation potential of hESC toward hepato-
cyte-like cells at all studied time points compared to non-
treated cells (Figures S4A and S4B). Continued treatment
with DOXY from day 2 to day 16 resulted in nearly
100% of differentiating ESC positive for tdT from day 4 on-
ward, with theMFI of tdT+ cells reachingmaximal levels on
day 8, which was sustained until day 16. When DOXY was
started on day 4, nearly 100% of cells were tdT+, but their
MFI did not increase over time, and remained lower than
when DOXY was started on day 2 (Figure 6D, left and
middle panels). More markedly, when DOXY was startedAuthors
Figure 5. Recombination of a Molecular Response Sensor in the AAVS1 Locus
(A) The RMCE donor vector pZ:F3-P NF-kB-F contains an NF-kB response element followed by tdT.
(B) NF-kB sensor response in undifferentiated cells with increasing doses of TNF-a.
(C) Relative gene expression (to non-induced cells) of NF-kB direct target genes on days 0 or 16.
(D) Sorting of tdT+ and tdT– cells after induction and percentages of tdT+ cells in undifferentiated wild-type (WT) or NF-kB sensor-RMCEL
before and after replating.
(E) TNF-a response on day 0 and 16 of hepatocyte differentiation.
(F) RMCE donor vector pZ:F3-P (cHS4)X4 NF-kB tdT-F containing insulators (blue arrows) and response to TNF-a induction (day 0 or 16)
without (NF-kB) or with insulators (In NF-kB) determined by FACS and expressed as percentage of tdT+ cells and MFI.
Data: mean ± SEM, n = 3 IEs. *p < 0.05 by Student’s t test.from days 8 and 12, only ±60% and ±35% of the ESC prog-
enywas tdT+ on day 16with a further pronounced decrease
inMFI. The percentage of tdT+ cells and protein expression
levels correlated well with the levels of 3flag-tdT transcripts
(Figure 6D, right panel).
This behavior could be caused by an insufficient
amount of DOXY in differentiating cells. Therefore, we
tested the effect of 5 and 10 mg/ml DOXY (higher doses
showed cytotoxicity). Although we found some increase
in the fraction of tdT+ cells and their MFI, this did not
reach levels seen when DOXY was added on day 2 in
each case (Figure S4C). Thus, although reduced respon-
siveness could in part be overcome by increasing DOXY
concentrations, we hypothesized that the tdT inducible
cassette could be specifically inhibited in the AAVS1 locus
during hepatocyte differentiation. Therefore, we included
insulators flanking the inducible cassette. InterestinglyStem Cell Rand contrary to what we observed for OCT4p or the
NF-kB sensor, insulators did not improve the reporter ac-
tivity in terms of the fraction of tdT+ cells or reporter
expression levels (MFI) in both the undifferentiated state
or in day 16 progeny when DOXY was added from d12
(Figure 6E; Figure S4D). Insulators improved reporter ac-
tivity only when DOXY was maintained for the duration
of the differentiation process.
To investigate whether the apparent AAVS1-mediated
inhibitory mechanism affected other lineages in vitro, we
also tested the inducible reporter expression system in
the mesodermal (endothelial cells and pericytes) and ecto-
dermal (motor neurons) lineages. Significantly more tdT+
cells were present in the differentiated progenies of both
systems than in the hepatocyte differentiation, indicating
that, during in vitro differentiation, inhibition exerted by
the AAVS1 locus was hepatocyte specific (Figure 6F).eports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 The Authors 925
Figure 6. Inducible Expression from the AAVS1 Locus during Hepatocyte Differentiation
(A) RMCE donor vector pZ:F3-P TetOn 3f-tdT-F for inducible expression (fully described in the Supplemental Information).
(B) Percentage of tdT+ cells in response to increasing doses of DOXY for 48 hr.
(C) Relative gene expression (to day 0) of m2rtTA during hepatocyte differentiation.
(D) Percentage of tdT+ cells, expression levels of tdT per cell (mean fluorescence intensity, MFI) and 3FLAG-tdT mRNA (relative gene
expression levels to –DOXY) with 3 mg/ml DOXY from the indicated time points.
(E) RMCE donor vector pZ:F3-P (cHS4)X4 TetOn 3f-tdT-F with insulators (blue arrows). Response to 3 mg/ml DOXY, initiated at the indicated
time points (on day 0 and 16), of the RMCELs without (itdT) and with insulators (In itdT) expressed as percentage of tdT+ cells.
(F) Directed differentiation of itdT RMCEL toward endoderm (hepatocytes, HP), ectoderm (motor neurons, MN), andmesoderm (endothelial
cells/pericytes, EC/P) with addition of 3 mg/ml DOXY during the last 7–8 days of differentiation (gray arrow). UD, undifferentiated cell; DE,
hepatic endoderm; HE, hepatic endoderm; HB, hepatoblast; NE, neuroectoderm; ME, mesoderm.
(G) Immunohistochemistry analysis of 3flag-tdT expression in teratomas of the itdT RMCEL in animals fed with or without DOXY.
Scale bars, 50 mm. Data: mean ± SEM of nR 3 IEs, *p < 0.05 by Student’s t test. Statistical significance is not represented in (B) and (D); ns
(not significant).To further understand the apparent lineage-specific
silencing, we assessed the expression of 3flag-tdT in vivo
in teratoma formation assays and found homogeneous
3flag expression in tissues representative of all the three
germ layers (Figure 6G), even if we could not identify hepa-
tocyte progeny in these teratomas.
In summary, these results suggest that the TRE integrated
in the AAVS1 locus may be specifically inhibited during he-
patocyte commitment in vitro in the absence of active tran-926 Stem Cell Reports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 Thescription from the start of differentiation, and that insula-
tors cannot overcome this. However, this mechanism
appears to not to affect endodermal lineages in vivo.DISCUSSION
We describe here the generation and full characterization
of hESC and iPSC master cell lines suitable for RMCE inAuthors
theAAVS1 locus. Previous studies describing RMCE systems
in hPSCs use only a positive selectable cassette, which leads
to the selection of cells wherein the transgene is recom-
bined in the pre-integrated FRT cassette, but also elsewhere
in the genome, requiring screening of individual colonies
to exclude random integrations (Du et al., 2009; Rama-
chandra et al., 2011; Tay et al., 2013; Zhu et al., 2013).
We here report a strategy using positive/negative selection
that allows for the generation of fully recombined hPSC
lines in 15 days with 100% targeting efficiency and free
of random integration events, that eliminates the need
for colony selection after RMCE and full characterization
of pluripotency or genome integrity.
A number of studies have suggested that the AAVS1 is a
safe harbor locus in hPSCs, as well as in other cell types.
However, our studies demonstrate that the AAVS1 locus is
not as ‘‘safe’’ as suggested, as transgene expression was var-
iable in both undifferentiated and hepatocyte committed
ESC progeny in vitro. The AAVS1 has been described as
an open chromatin locus by DNase hypersensitive assays
and ChIP, but these studies did not cover the region tar-
geted by the ZFNs in PSCs (Lamartina et al., 2000; Lom-
bardo et al., 2011; Ogata et al., 2003; van Rensburg et al.,
2013). No analysis of the DNAmethylation status of the lo-
cus was carried out. Here, we demonstrate that the region
targeted by the ZFNs used in this study, but also in other
studies and by TALENs and CRIPS/Cas9 (Hockemeyer
et al., 2009, 2011; Mali et al., 2013), can exert silencing
in vitro via induction of de novo DNA methylation in un-
differentiated hESC. The insulator activity and/or range of
action described for the DHR region appears therefore not
to ensure expression of all transgenes in this site (Ogata
et al., 2003). Inhibition was observed for transgenic
OCT4p activity, but the universal CAGGS promoter (in
the master cell line and RMCE lines) or the NF-kB sensor
was stably active without the need of insulators. Hence, in-
hibition by DNA methylation possibly occurs in a
sequence-dependent manner (Feltus et al., 2003).
A number of lineage-specific promoters flanked by insu-
lators showed variable activity during hepatocyte differen-
tiation in vitro: the GSC promoter reported efficiently for
GSC-expressing cells, whileAPOeAATp significantly under-
estimated the real percentage of AAT-expressing cells, as
well as the neural HB9p. Independently of their efficacy
when integrated in the AAVS1, all these promoters success-
fully allowed identification, isolation, and characterization
of the respective cell populations. However, activity of the
AAT, AFP, and HB9 promoters in the AAVS1 strongly
differed from what was previously reported when inte-
grated randomly in the hESC genome to perform identifi-
cation of AAT+, AFP+, and HB9+ cells, respectively (Duan
et al., 2007; Ishii et al., 2008; Wainger et al., 2014). In
random transgenesis, cells that robustly activate the trans-Stem Cell Rgenic promoters in a specific manner are usually selected.
This could be the result of multiple copy insertions or posi-
tion effects due to proximity to regulatory regions that
enhance the specific promoter activity, both improving
the promoter activity even if some important regulatory
elements are not present in the cloned fragment. The
absence of AAVS1-mediated inhibition during neural dif-
ferentiation (Figure 6F) suggests that the underperform-
ance of the HB9p must be linked to the promoter fragment
used in our study and proves that functionally validated
promoters do not necessarily reproduce the activity of pre-
vious studies when integrated as a single copy in the
genome in the AAVS1 locus. Instead, apparent AAVS1-
mediated transgene inhibition during hepatic commit-
ment (Figure 6F) may partially explain the malfunctioning
of the hepatic promoters independently of the compe-
tences of the cloned fragment. Whether additional regula-
tory elementsmight be needed to achieve proper activity of
the APOeAATp, AATp, AFPp when recombined into the
AAVS1 locus is not known, and it is beyond the scope of
our work.
Inducible expression during hepatocyte differentiation
from the AAVS1 showed that only a fraction of cells re-
sponded to DOXY when it was applied later during differ-
entiation, even when using higher concentrations of
DOXYor insulators. The observed AAVS1-mediated inhibi-
torymechanismof the TRE construct is in linewith the pre-
viously observed notion that reduced gene expression can
trigger silencing (Oyer et al., 2009). This may explain our
observations that uninsulated transgenes, such as the
ones driven by the CAGGS constitutive promoter, the
NF-kB sensor, or the continuously active TRE, were not in-
hibited when introduced in the AAVS1 locus during hepa-
tocyte differentiation. The apparent discrepancy between
the inducible TRE construct and the NF-kB sensor activa-
tion at later stages of the differentiationmight be explained
because unlike the un-induced TRE, NF-kB is already acti-
vated even in in the absence of TNF-a administration,
albeit at low levels, likely due to culture-induced stress (Fig-
ure 5E). Interestingly, in contrast with hepatocyte differen-
tiation, the uninsulated inducible tdT cassette could be
efficiently activated in hESC-derived motor neurons and
mesodermal cells, and ubiquitous reporter expression was
seen in cells of the three germ layers in teratomas in vivo,
although we cannot definitely state that inhibition does
not occur in hepatocytes in vivo. Even if our studies did
not show faithful activity of the HB9p, the studies using
the inducible system are consistent with other reports
demonstrating successful neural and hematopoietic line-
age identification by promoter constructs in the AAVS1 lo-
cus without the need of insulators (Chang and Bouhassira,
2012; Sullivan et al., 2014; Tiyaboonchai et al., 2014;
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reporting stable transgene expression (Hockemeyer et al.,
2011; Qian et al., 2014). Why cHS4 insulators were not
able to block the AAVS1-mediated inhibition of the TRE
during hepatocyte differentiation, and potentially the hep-
atoblast/hepatocyte lineage-specific promoters, but were
functional when usedwith theOCT4p andNF-kB sensor re-
mains unknown. Thus, the lack of proper hepatoblast/he-
patocyte-specific promoter activity might be explained by
both AAVS1-mediated inhibition during hepatocyte differ-
entiation (not blocked by insulators as for TRE) and lack of
important regulatory elements.
One of the parameters that defines a safe harbor locus is
its capability to allow stable, faithful, and predictable trans-
gene expression in all different cell types. Independently of
the competences of particular lineage-specific promoters,
our results demonstrate that complex genetic and/or epige-
netic regulatory mechanisms, including DNA methylation
and other unknownmechanisms, act in the human AAVS1
locus in vitro in hPSCs in a sequence and lineage-depen-
dent manner. AAVS1 is not able to support faithful and pre-
dictable transgene expression in undifferentiated hPSCs
(OCT4 promoter without insulators), nor in a lineage-
dependent manner (at least in the hepatocyte lineage)
in vitro, though transgene silencing is not found in vivo.
Mosaicism of transgene expression in safe harbor loci was
similarly described for the well-characterized murine
Rosa26 or ColA1 loci during in vitro and in vivo differenti-
ation of ESC, even with the use of insulators (Beard et al.,
2006; Haenebalcke et al., 2013). Our observations therefore
contradict previous reports describing AAVS1 as a universal
safe harbor locus for stable transgene expression in hPSCs
in vitro (Lombardo et al., 2011; Qian et al., 2014; Smith
et al., 2008). However, most of the in vitro studies have
used strong constitutive promoters that appear to be refrac-
tory to AAVS1-exerted inhibition, as we show here for the
CAGGS promoter, or do not assess transgene expression
in hepatocytes in vitro. In summary, we demonstrate that
the AAVS1 locus in human cells does not allow universal
expression of transgenes and hence does not meet the
true safe harbor locus definition.Whether targeting in a hy-
pomethylated region within the AAVS1 would allow better
transgene expression in hepatocytes in vitro needs to still
be assessed.
With the advent of CRISPR-Cas9 technology, creation of
knockout or knockin lines has significantly improved. As,
for example, knockin (-add-on) strategies constitute the
most faithful method to perform lineage identification
and tracing, the CRISPR-Cas9 based approach can be
considered superior compared with the introduction of
lineage tracing and identification cassettes in the AAVS1 lo-
cus. In addition, with the generation of the iCRISPR meth-
odology, inducible expression of Cas9 from the AAVS1
(Gonza´lez et al., 2014), creation of transgenic hPSCs has928 Stem Cell Reports j Vol. 5 j 918–931 j November 10, 2015 j ª2015 Thebecome more robust and efficient than approaches using
co-transfection of CRISPR and guide RNAs; one could argue
that the utility of master cell lines with docking sites in the
AAVS1 locus is no longer scientifically relevant. However,
the technology described here still provides a number of
advantages over the use of CRISPR-Cas9 or the iCRISPR
platform: (1) a transgenic line can be generated in 2 weeks,
without the need for identification of off-target effects or
characterization of pluripotency and genome integrity of
the recombinant lines; and (2) it allows the creation of a se-
ries of applications that require the use of a defined isogenic
locus, which allows side-by-side comparisons between
different transgenes. As a matter of fact, the AAVS1 locus
has been proved suitable for most of these applications in
hPSCs during the recent past years (Garc¸on et al., 2013;
Gonza´lez et al., 2014; Raitano et al., 2015; Rio et al.,
2014; Wang et al., 2012).
In conclusion, we generated an RMCE-based method in
the AAVS1 locus of hPSCs (applicable to other locus if
desired) that enables fast and efficient generation of trans-
genic lines, andwe demonstrate that theAAVS1 locus is not
as safe as believed, though it remains a confirmed valuable
tool for transgenesis in hPSCs for several applications
in vitro and in vivo. The use of lineage-specific promoters
or inducible systems during directed differentiation re-
quires that promoter constructs are tested individually in
specific lineages to ensure that they are not impacted by
AAVS1-mediated inhibitory effects causing inefficient
expression in vitro.EXPERIMENTAL PROCEDURES
Human ESC/iPSC Differentiation
hESC and hiPSCwere harvested using trypsin (GIBCO) or accutase
(Sigma), respectively, and plated onto 1.6% matrigel (BD) coated
dishes at 7 3 104 cells/cm2 with mTeSR1 medium. 2–3 days after
plating, differentiation was initiated as described previously (Roe-
landt et al., 2012).
Generation of the Master Cell Lines and RMCE Lines
Two million H9-ESC or iPSC were transfected with 10 mg of donor
vector and 3 mg of AAVS1 ZFNmRNA using the hESC Nucleofector
Solution Kit 2 (Amaxa) and programs A13 or F16 for cells cultured
on iMEF or feeder free, respectively. Selection was performed with
25–50 mg/ml of Hygromycin B (Sigma-Aldrich) for 10–15 days. Re-
combinant colonies were manually picked and expanded for
further characterization. RMCE was performed by Nucleofection
as described. Further details on constructs generation, description,
and molecular characterization of recombinant lines can be found
in the Supplemental Information.
NF-kB Reporter Activity Induction
Undifferentiated hESC were incubated with increasing concentra-
tions of TNF-a for 48 hr. For the rest of experiments, day 0 and 16Authors
hepatocyte-progenies were treated with 100 ng/ml TNF-a for 24 hr
and were analyzed by FACS.
Flow Cytometry and Cell Sorting
TRA-1-60 staining (BD Biosciences, antibody and isotype control)
was performed according to manufacturer’s instructions. FACS
analysis and sorting were carried out on FACS Canto and FACS
Aria III (BDBiosciences), respectively. Data analysis was done using
the FACS Diva (BD) or FlowJo software.
Statistical Analysis
Aminimumof three independent experiments (n = 3 independent
experiments [IEs]) were carried out. Data values represent average
±SEM and were subject to the two-tailed Student’s t test. Values
of *p < 0.05, **p < 0.01, and ***p < 0.001 were considered statisti-
cally significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and five tables and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.
004.
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